A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology

[1]  T. Pisitkun,et al.  STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation , 2020, iScience.

[2]  T. Molina,et al.  Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling , 2020, The Journal of experimental medicine.

[3]  J. Enghild,et al.  STEEP mediates STING ER exit and activation of signaling , 2020, Nature Immunology.

[4]  I. Bruce,et al.  Trial of Anifrolumab in Active Systemic Lupus Erythematosus. , 2019, The New England journal of medicine.

[5]  C. Boularan,et al.  The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma , 2019, Oncogene.

[6]  Zhijian J. Chen,et al.  Autophagy Induction via STING Trafficking Is a Primordial Function of the cGAS Pathway , 2019, Nature.

[7]  M. Gatto,et al.  New therapeutic strategies in systemic lupus erythematosus management , 2018, Nature Reviews Rheumatology.

[8]  M. Altman,et al.  Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING. , 2018, ACS medicinal chemistry letters.

[9]  Lihua Song,et al.  The Cyclopeptide Astin C Specifically Inhibits the Innate Immune CDN Sensor STING. , 2018, Cell reports.

[10]  H. Shu,et al.  TMED2 Potentiates Cellular IFN Responses to DNA Viruses by Reinforcing MITA Dimerization and Facilitating Its Trafficking. , 2018, Cell reports.

[11]  Arup Sarkar,et al.  Type‐1 interferons prolong the lifespan of neutrophils by interfering with members of the apoptotic cascade , 2018, Cytokine.

[12]  R. Sun,et al.  The Ca2+ sensor STIM1 regulates type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum , 2018, Nature Immunology.

[13]  H. Shu,et al.  SNX8 modulates innate immune response to DNA virus by mediating trafficking and activation of MITA , 2018, PLoS pathogens.

[14]  Jiaguo Huang,et al.  Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance. , 2018, Protein and peptide letters.

[15]  A. Thielke,et al.  Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling , 2018, Proceedings of the National Academy of Sciences.

[16]  Y. Kawasawa,et al.  B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells , 2018, Cell reports.

[17]  G. Turcatti,et al.  Targeting STING with covalent small-molecule inhibitors , 2018, Nature.

[18]  M. Ueda,et al.  Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus , 2018, Annals of the rheumatic diseases.

[19]  S. Thiel,et al.  The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus , 2018, The Journal of Rheumatology.

[20]  E. Fikrig,et al.  UBXN3B positively regulates STING-mediated antiviral immune responses , 2018, Nature Communications.

[21]  D. Portnoy,et al.  STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. , 2018, Cell reports.

[22]  J. Nyengaard,et al.  Attenuation of cGAS‐STING signaling is mediated by a p62/SQSTM1‐dependent autophagy pathway activated by TBK1 , 2018, The EMBO journal.

[23]  Y. Crow,et al.  An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation , 2018, Neurology.

[24]  Lei Jin,et al.  The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans , 2018, PLoS pathogens.

[25]  G. Gilkeson,et al.  Mouse models of lupus: what they tell us and what they don’t , 2018, Lupus Science & Medicine.

[26]  F. Rieux-Laucat,et al.  Type I interferon-mediated autoinflammation due to DNase II deficiency , 2017, Nature Communications.

[27]  M. Ascano,et al.  Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice , 2017, Nature Communications.

[28]  A. Villunger,et al.  Signalling strength determines proapoptotic functions of STING , 2017, Nature Communications.

[29]  J. An,et al.  cGAS Expression in Patients with Systemic Lupus Erythematosus. , 2016 .

[30]  J. Nyengaard,et al.  Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS , 2016, Nature Communications.

[31]  C. Fiehn,et al.  Familial chilblain lupus due to a gain-of-function mutation in STING , 2016, Annals of the rheumatic diseases.

[32]  G. Hartmann,et al.  Discriminating self from non-self in nucleic acid sensing , 2016, Nature Reviews Immunology.

[33]  H. Shu,et al.  iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING , 2016, Nature Immunology.

[34]  G. Barber,et al.  Activation of STING requires palmitoylation at the Golgi , 2016, Nature Communications.

[35]  Virginia Pascual,et al.  Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients , 2016, Cell.

[36]  V. Hornung,et al.  Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses , 2016, Nature Communications.

[37]  Zhijian J. Chen,et al.  Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases , 2015, Proceedings of the National Academy of Sciences.

[38]  Nan Yan,et al.  STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease. , 2015, Cell host & microbe.

[39]  M. You,et al.  STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells , 2015, Molecules and cells.

[40]  N. Grishin,et al.  Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation , 2015, Science.

[41]  C. Mohan,et al.  Suppression of systemic autoimmunity by the innate immune adaptor STING , 2015, Proceedings of the National Academy of Sciences.

[42]  T. Molina,et al.  Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. , 2014, The Journal of clinical investigation.

[43]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[44]  Ying Wang,et al.  STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. , 2014, Immunity.

[45]  Ha Won Kim,et al.  Activated STING in a vascular and pulmonary syndrome. , 2014, The New England journal of medicine.

[46]  Zhijian J. Chen,et al.  Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects , 2013, Science.

[47]  K. Kodys,et al.  STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease , 2013, Proceedings of the National Academy of Sciences.

[48]  Nan Yan,et al.  Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses , 2013, Science.

[49]  A. Bowie,et al.  Immune sensing of DNA. , 2013, Immunity.

[50]  T. Mayadas,et al.  Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. , 2012, Immunity.

[51]  H. B. Moeller,et al.  Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING , 2012, Nature Immunology.

[52]  Zhijian J. Chen,et al.  STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway , 2012, Science Signaling.

[53]  G. Tsokos,et al.  Systemic lupus erythematosus. , 2011, The New England journal of medicine.

[54]  F. Rixon,et al.  Activation of Autophagy by α-Herpesviruses in Myeloid Cells Is Mediated by Cytoplasmic Viral DNA through a Mechanism Dependent on Stimulator of IFN Genes , 2011, The Journal of Immunology.

[55]  A. Bowie,et al.  IFI16 is an innate immune sensor for intracellular DNA , 2010, Nature Immunology.

[56]  M. Colonna,et al.  Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response , 2010, The Journal of experimental medicine.

[57]  K. Ishii,et al.  Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response , 2009, Proceedings of the National Academy of Sciences.

[58]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[59]  K. Rajewsky,et al.  Novel Reporter Mouse Reveals Constitutive and Inflammatory Expression of IFN-β In Vivo1 , 2009, The Journal of Immunology.

[60]  M. Rewers,et al.  IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. , 2008, Human molecular genetics.

[61]  C. Bao,et al.  Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients , 2008, Arthritis research & therapy.

[62]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[63]  D. Barnes,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.

[64]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[65]  Hong-Hsing Liu,et al.  The specific and essential role of MAVS in antiviral innate immune responses. , 2006, Immunity.

[66]  R. Dummer,et al.  Induction of Genes Mediating Interferon-dependent Extracellular Trap Formation during Neutrophil Differentiation* , 2004, Journal of Biological Chemistry.

[67]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[68]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[69]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[70]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[71]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[72]  M. Shlomchik,et al.  The Roles of B Cells in MRL/lpr Murine Lupus , 1997, Annals of the New York Academy of Sciences.

[73]  G. Tsokos,et al.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. , 1989, Journal of immunology.